[HTML][HTML] Neurological involvement of coronavirus disease 2019: a systematic review

M Ghannam, Q Alshaer, M Al-Chalabi, L Zakarna… - Journal of …, 2020 - Springer
Abstract Background In December 2019, unexplained cases of pneumonia emerged in
Wuhan, China, which were found to be secondary to the novel coronavirus SARS-CoV-2. On …

Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: a systematic review and meta-analysis

S Shah, K Shah, SB Patel, FS Patel, M Osman… - Cardiology in …, 2020 - journals.lww.com
The 2019 novel coronavirus, declared a pandemic, has infected 2.6 million people as of
April 27, 2020, and has resulted in the death of 181,938 people. d-dimer is an important …

Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination—United States, December 2020 to August 2021

I See, A Lale, P Marquez, MB Streiff… - Annals of internal …, 2022 - acpjournals.org
Background: Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-
threatening condition associated with adenoviral-vectored COVID-19 vaccination. It presents …

D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases

M Soni, R Gopalakrishnan, R Vaishya… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims COVID-19 is a multi-system disease, with coagulation abnormalities.
D-dimer levels are increased in this disease. We aimed to determine the association of D …

Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19

JS Berger, D Kunichoff, S Adhikari, T Ahuja… - … , and vascular biology, 2020 - Am Heart Assoc
Objective: To determine the prevalence of D-dimer elevation in coronavirus disease 2019
(COVID-19) hospitalization, trajectory of D-dimer levels during hospitalization, and its …

[HTML][HTML] Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19

AK Maher, KL Burnham, EM Jones, MMH Tan… - Nature …, 2022 - nature.com
Although alterations in myeloid cells have been observed in COVID-19, the specific
underlying mechanisms are not completely understood. Here, we examine the function of …

D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications

J Favresse, G Lippi, PM Roy, B Chatelain… - Critical reviews in …, 2018 - Taylor & Francis
D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …

Right ventricular dysfunction in critically ill COVID-19 ARDS

C Bleakley, S Singh, B Garfield, M Morosin… - International journal of …, 2021 - Elsevier
Aims Comprehensive echocardiography assessment of right ventricular (RV) impairment
has not been reported in critically ill patients with COVID-19. We detail the specific …

Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management

SR Savla, KS Prabhavalkar, LK Bhatt - Expert review of anti …, 2021 - Taylor & Francis
ABSTRACT Introduction SARS-CoV-2, the causative agent of COVID-19, attacks the
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …

Putting humpty dumpty back together again: what does protein quantification mean in bottom-up proteomics?

DL Plubell, L Käll, BJ Webb-Robertson… - Journal of proteome …, 2022 - ACS Publications
Bottom-up proteomics provides peptide measurements and has been invaluable for moving
proteomics into large-scale analyses. Commonly, a single quantitative value is reported for …